BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25173083)

  • 1. Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.
    Peng Q; Li H; Lao X; Deng Y; Chen Z; Qin X; Li S
    Infect Genet Evol; 2014 Oct; 27():375-81. PubMed ID: 25173083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of polymorphisms of interleukin-2 gene and HBV DNA copies in patients with chronic hepatitis B].
    Wei YS; Lan Y; Yuan XH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):889-92. PubMed ID: 19105930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the interleukin-2 polymorphisms with interleukin-2 serum levels and risk of nasopharyngeal carcinoma.
    Wei YS; Lan Y; Zhang L; Wang JC
    DNA Cell Biol; 2010 Jul; 29(7):363-8. PubMed ID: 20438365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study.
    Liu Y; Xie L; Zhao J; Huang X; Song L; Luo J; Ma L; Li S; Qin X
    Medicine (Baltimore); 2015 Apr; 94(13):e702. PubMed ID: 25837767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
    Li Y; Xie Q; Lu F; Zhao J; Mao P; Li Z; Liu S; Zhuang H
    Liver Int; 2010 Jan; 30(1):112-8. PubMed ID: 19840254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
    Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. +49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population.
    Gu X; Qi P; Zhou F; Ji Q; Wang H; Dou T; Zhao Y; Gao C
    Hum Immunol; 2010 Jan; 71(1):83-7. PubMed ID: 19778566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
    Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
    Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population.
    Wu Z; Sun Y; Huang Y; Zhu S; Feng Y; Ye H; Liu C; Tang S
    Oncotarget; 2016 Nov; 7(47):77968-77977. PubMed ID: 27792999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
    Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
    Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-related hepatocellular carcinoma in Hunan Han population].
    Liu G; Lu GX
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1838-40. PubMed ID: 20813679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
    Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
    Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population.
    Gu X; Qi P; Zhou F; Ji Q; Wang H; Dou T; Zhao Y; Gao C
    Hum Genet; 2010 Jan; 127(1):75-81. PubMed ID: 19813023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
    He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
    Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent effect of IFNAR-1 genetic polymorphism on the long-term pathogenesis of chronic HBV infection.
    He XX; Chang Y; Jiang HJ; Tang F; Meng FY; Xie QH; Li PY; Song YH; Lin JS
    Viral Immunol; 2010 Jun; 23(3):251-7. PubMed ID: 20565290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
    Cai X; Peng S; Xiao X; Huang Z; Zhang P
    Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population.
    Zhang PA; Wu JM; Li Y; Yang XS
    World J Gastroenterol; 2005 Mar; 11(11):1594-8. PubMed ID: 15786533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation analysis of IL-37 gene polymorphisms and susceptibility to chronic HBV infection among Han people in Central China.
    Cheng H; Sun F; Ouyang Y; Li C
    Int J Immunogenet; 2023 Dec; 50(6):299-305. PubMed ID: 37735774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma.
    Ren S; Lu J; Du X; Huang Y; Ma L; Huo H; Chen X; Wei L
    Cancer Immunol Immunother; 2012 Sep; 61(9):1433-9. PubMed ID: 22310928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China.
    Chen Y; Zhang H; Liao W; Zhou J; He G; Xie X; Fei R; Qin L; Wei L; Chen H
    J Exp Clin Cancer Res; 2013 Jun; 32(1):39. PubMed ID: 23759077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.